ICU Medical (ICUI) Set to Announce Quarterly Earnings on Tuesday

ICU Medical (NASDAQ:ICUI) is scheduled to post its quarterly earnings results after the market closes on Tuesday, May 7th. Analysts expect ICU Medical to post earnings of $0.84 per share for the quarter. ICU Medical has set its FY24 guidance at $4.40-5.10 EPS and its FY 2024 guidance at 4.400-5.100 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 EPS for the quarter, topping the consensus estimate of $0.85 by $0.39. The company had revenue of $587.86 million during the quarter, compared to the consensus estimate of $564.77 million. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. On average, analysts expect ICU Medical to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

ICU Medical Stock Performance

ICUI stock opened at $99.99 on Friday. The company has a quick ratio of 1.06, a current ratio of 2.53 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $2.44 billion, a price-to-earnings ratio of -81.29 and a beta of 0.72. ICU Medical has a 12 month low of $78.28 and a 12 month high of $212.43. The firm has a 50 day moving average of $100.98 and a two-hundred day moving average of $97.28.

Wall Street Analysts Forecast Growth

Separately, KeyCorp boosted their target price on shares of ICU Medical from $134.00 to $136.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th. One investment analyst has rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $123.00.

Insiders Place Their Bets

In other news, VP Daniel Woolson sold 791 shares of the business’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the sale, the vice president now directly owns 13,980 shares in the company, valued at $1,373,814.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, Director George A. Lopez sold 7,978 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $101.87, for a total value of $812,718.86. Following the completion of the sale, the director now directly owns 877,343 shares in the company, valued at $89,374,931.41. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Daniel Woolson sold 791 shares of the company’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the transaction, the vice president now owns 13,980 shares of the company’s stock, valued at $1,373,814.60. The disclosure for this sale can be found here. Insiders sold 24,262 shares of company stock valued at $2,545,532 over the last ninety days. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.